• Treatment Intensity Should Be Personalized in Women with HER2-positive Breast Cancer, Study Says
  • Young Women More Likely to Face Aggressive BC Types, But Proper Treatment Improves Outcomes
  • Experimental Antibody Therapy Leads to Significant Responses in HER2-positive Breast Cancer, Phase 2 Trial Shows
  • Here I Am
  • Radiation Therapy Reduces Chances of Breast Cancer Returning in Women with Early, Hormone-Positive Disease, Trial Shows
  • Kadcyla Approved in US for Some HER2-positive Early Breast Cancer Patients
  • SHARE Introduces My MBC & Me App for Metastatic Breast Cancer Patients
  • New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer
  • Walking on Broken Glass
  • Clinical Trial Will Test Investigational Therapy Targeting ‘Dormant’ Breast Cancer Cells
  • Surgery That Removes All Traces of Breast Cancer Stimulates Protective Anticancer Immune Response, Mouse Study Suggests
  • Liposomal Irinotecan Shows Promising Phase 1 Results in Heavily Treated Breast Cancer Patients